Background:– The metabolic syndrome (MS) is described as clusters of abnormalities including abdominal obesity , insulin resistance , hypertension , hyperglycemia , increased triglycerides and decreased high density lipoprotein cholesterol (HDL–C)1.

Patients with diabetes have metabolic syndrome with estimated prevalence of 69.9 per cent for whites, 64.8 percent for blacks, and 62.4 percent for Mexican Americans.

Material and Methods:– The study was cross sectional. A total of 384 type II DM patients  among these 384 patients males were 203  (52.86%) aged 46–66 years and females  were 181 (47.14%) aged 45–65 years were enrolled in the study. Blood Pressure , serum lipid profile , waist circumference were measured in this study. Glycated hemoglobin (HbA1c) test was used to confirm Type II DM among the new cases. Metabolic syndrome was diagnosed using modified National educational program adult treatment panel–III NCEP ATP–III criteria.

Result :– Among 384 diabetic patients, metabolic syndrome was present in 280 patients. The incidence was highest in 50–60 year‘s age group and lowest in 31–40 years age group. Metabolic syndrome was predicted highest by Triglycerides  (62.14% patients,47% male & 53% females ) followed by HDL (61%) and than by Hypertension (60%). Sex wise analysis of data shows that HDL in female (48%) and hypertension in males (30%) was strongest predictor indicators of MS in type II DM.

Conclusion:– Based on this study we find that triglyceride, hypertension and HDL together can be used as predictor for MS in type II DM, out of these three serum triglyceride may be considered as the strongest single predictor of MS in type II DM where as HDL in female and hypertension in males may be used as strongest predictors of MS in type II DM.